Trovagene, Inc. (TROV) has 23 open-market insider trades by 12 insiders since 2012. The most active filer is Stanley Tennant, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Management Llc Bridger | — | — | 3 | $5.3M | 2016-11-11 |
| Roberto Mignone | — | — | 1 | $1.4M | 2015-02-27 |
| Stanley Tennant | Dir | — | 7 | $296K | 2018-06-08 |
| Robert Merrill Hunter | 10% | — | 1 | $200K | 2012-04-13 |
| Thomas Adams Ph.D. | Dir | — | 1 | $157K | 2018-01-02 |
| Gabriel Cerrone | Dir | — | 3 | $152K | 2012-08-20 |
| Antonius Schuh | CEO | — | 1 | $109K | 2015-08-12 |
| Steve Zaniboni | Former CFO | — | 2 | $106K | 2016-04-21 |
| Rodney S. Markin | Dir | — | 1 | $35K | 2018-06-20 |
| Mark Erlander | Chief Scientific Officer | — | 1 | $10K | 2020-01-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Rodney S. Markin | Director | Buy | $35K | 2018-06-20 |
| John P. Brancaccio | Director | Buy | $8K | 2018-06-08 |
| Stanley Tennant | Director | Sell | $6K | 2017-09-05 |
| Stanley Tennant | Director | Buy | $21K | 2016-12-19 |
| Stanley Tennant | Director | Buy | $30K | 2016-12-16 |
| William J. Welch | CEO | Buy | $10K | 2016-12-16 |
Companies that share insiders with TROV, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mark Erlander | Chief Scientific Officer | Buy | $10K | 2016-12-14 |
| Management Llc Bridger | — | Buy | $993K | 2016-11-11 |
| Steve Zaniboni | CFO | Buy | $81K | 2015-08-12 |
| Antonius Schuh | CEO | Buy | $109K | 2015-08-12 |
| Stanley Tennant | Director | Buy | $61K | 2015-08-12 |
| Management Llc Bridger | 10% | Buy | $1.2M | 2015-07-17 |
| Management Llc Bridger | 10% | Buy | $2.1M | 2015-04-02 |
| Roberto Mignone | — | Buy | $1.4M | 2015-02-25 |
| Management Llc Bridger | 10% | Buy | $2.0M | 2015-02-06 |